These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Demma LJ; Winkler AM; Levy JH Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317 [TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia. Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia. Althaus K; Pelzl L; Hidiatov O; Amiral J; Marini I; Bakchoul T Thromb Res; 2019 Aug; 180():55-61. PubMed ID: 31220752 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies. Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918 [TBL] [Abstract][Full Text] [Related]
13. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124 [TBL] [Abstract][Full Text] [Related]
14. Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopenia. Vianello F; Sambado L; Scarparo P; Lombardi A; Bernardi D; Plebani M; Fabris F Clin Chem Lab Med; 2015 Feb; 53(2):257-63. PubMed ID: 25324455 [TBL] [Abstract][Full Text] [Related]
15. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT. Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633 [TBL] [Abstract][Full Text] [Related]
16. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis. Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366 [TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery. Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844 [TBL] [Abstract][Full Text] [Related]
18. Testing for heparin-induced thrombocytopenia antibodies. Warkentin TE; Sheppard JA Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164 [TBL] [Abstract][Full Text] [Related]